- About
-
Our Research
- Microvascular Research Group
-
Arterial Inflammation and Redox Biology Group
- The role of bilirubin in cardiovascular and metabolic diseases
- Improving our ability to identify individuals at high risk of suffering a heart attack
- Examining the role of extracellular myeloperoxidase in the pathogenesis, identification and treatment of high-risk unstable and ruptured atherosclerotic plaque
- Regulation of cell-to-cell communication during inflammation by tryptophan-derived cis-WOOH
- Overcoming CoQ deficiencies in cardiovascular and metabolic diseases by modulating endogenous regulators of CoQ synthesis
- Cardiovascular-protective Signalling and Drug Discovery
-
Cardiometabolic Disease
- Novel therapeutic strategies in type 2 diabetes
- Dietary-microbiome-metabolic interactions in cardiovascular disease
- Leveraging cardiac substrates to improve cardiac energetics and outcomes in diabetic cardiomyopathy and HFpEF
- Targeted therapy in type 2 diabetes
- A key metabolic switch in cardiometabolic disease
- Novel pathways in ischaemic heart disease
- Vascular Immunology
- Vascular Complications
- Cardiovascular Neuroscience
-
Coronary Diseases
- Determining the effects of colchicine on smooth muscle cell plasticity in advanced atheroma
- Determining the anti-atherosclerotic properties of TRAIL
- Effects of colchicine on metabolomic profiles in coronary disease patients
- Effects of colchicine on miRNA levels in coronary disease patients
- Effects of colchicine on prognostically significant vascular endpoints in patients post-acute coronary syndrome (ACS)
- Effects of colchicine on neutrophil function in acute coronary syndrome (ACS) patients
- Salutary effects of colchicine in a murine model of type 2 diabetes
- The effects of colchicine on the development and regression of atherosclerosis
- The effects of colchicine on immune cell migration in acute coronary syndrome patients
- Cardiovascular Medical Devices
-
Thrombosis
- Developing a novel preclinical ischaemic stroke model
- Understanding the mechanisms leading to microvascular dysfunction and poor cerebral perfusion in stroke
- Developing safer anti-clotting agents derived from “Mother Nature”
- Biomechanical sensing and blood clot formation: Solving a sticky clotting problem in diabetes
- Developing novel approaches to the treatment of ischaemic stroke
- Platelet death as an important regulator of blood clot formation
- “Bad Blood”: Unravelling the link between gut ischemia and remote organ injury
- Haematology Research
- Atherosclerosis and Vascular Remodelling
-
Clinical Research
- Optimising exercise prescription and delivery in congenital heart disease – The Congenital Heart Fitness Intervention Trial: CH-FIT
- Australian-wide study of the outcomes and burden of congenital heart disease across the life-course
- Improving health outcomes in congenital heart disease for young adults, their families and the health system
- Young adults with congenital heart disease
- Early detection of pulmonary vascular disease
- Detecting heart attacks
-
Heart Rhythm and Stroke Prevention
-
News
- Dr Melissa Farnham awarded Diabetes Australia grant
- HRI sheds further light on relationship between diet and cardiometabolic disease
- HRI study confirms role of GPs and novel eHealth tools for AF screening to prevent stroke
- Dr Lining (Arnold) Ju – Young Tall Poppy Science Award
- Dr Mary Kavurma awarded ACvA Research Catalyst Grant
- Dr Ashish Misra awarded Perpetual IMPACT grant
- Unprecedented drug design minimising side effects
- Global media interest in HRI’s breakthrough anti-clotting drug for COVID-19
- HRI researchers on cusp of worldwide breakthrough in COVID-19 treatment
- View news archives
-
Health
-
Your health
- How to help your body recover after exercise
- Extra hygiene precautions won't weaken our immune systems
- Top 7 superfoods to try
- Which face mask should I wear?
- 4 unusual things we’ve learned about the coronavirus since the start of the pandemic
- How to set up your own exercise program
- Managing iron levels
- People with coronavirus are at risk of blood clots and strokes
- How to stay fit and active at home during the coronavirus self-isolation
- View health archives
-
Learn
- Obstructive sleep apnoea
- High blood pressure
- Inactivity and a sedentary lifestyle
- Alcohol
- Smoking
- Obesity and overweight
- High cholesterol
- Heart failure
- Heart attack
- Atherosclerosis
- Stroke
- Risk factors for cardiovascular disease
- Women and heart disease
- Preeclampsia
- Diabetes
- Peripheral artery disease
- Atrial fibrillation
- Cardiovascular disease
-
Your health
-
Stories
- Have a story you’d like to share?
- Liesl’s story
- Phil's story
- Bruna's story
- Jean's story
- John's story
- Ross' story
- Brad's story
- Carly's story
- Jake's story
- Alistair's story
- Kerri's story
- Beverley's story
- Laura's story
- Renee's story
- Faye's story
- Greg and Jo's story
- Cara's story
- Basil and Siana's story
- Jason's story
- Phil's story
-
Join Us
- Why Work at HRI?
- Benefits
- Student Opportunities
- Summer Scholarships
- Postdoctoral and Fellowship Opportunities
- Jobs Available
- HRI Careers Newsletter
- Our Stories - Life at HRI
- Jessica Maclean’s advice for a career in medical research
- Melissa Farnham's career in medical research
- Xuyu Liu's advice for a career in medical research
- Manisha Patil's career in medical research
- Dr Yen Chin Koay's video transcript about her career at HRI.
- HRI Open Day
- Summer Scholars 2020
- High School Students' Work Experience
- Contact
amatör porno anal sikiş
olgun porno hd porno
brazzers tecavüz sikiş
sikiş izle rokettube
porno porno seyret
sikiş izle sex izle
türk sex anal porno
COVID-19
HRI breakthrough treatment for blood clots in COVID-19 patients
HRI breakthrough for COVID-19 patients
Read full article